IDENTIFICATION AND CHARACTERIZATION OF SURFACE-RECEPTORS FOR HISTAMINE IN THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE HL-60 - COMPARISON WITH HUMAN PERIPHERAL NEUTROPHILS
- 1 January 1982
- journal article
- research article
- Vol. 22 (3) , 547-553
Abstract
The magnitude, potency, duration and specificity of histamine-induced cAMP formation were compared in human promyelocytic leukemic HL-60 cells and in human peripheral neutrophils. In HL-60 cells incubated at 37.degree. in the absence of phosphodiesterase inhibitor, histamine caused a 20-fold stimulation of basal cAMP levels, with an EC50 [media effective concentration] of 5 .times. 10-6 M. Typical H2 receptors were involved as shown by the relative potencies of the H1-selective agonists, 2-(2-pyridyl)ethylamine (PEA) and 2-(2-amino-ethyl)thiazole (AET), and the H2-selective agonists, impromidine and 4-(methyl)histamine(4-MH), impromidine > histamine > 4-MH > AET > PEA. Impromidine had mixed agonist-antagonist properties as shown by the rightward shift of the concentration-response curve of histamine (EC50 = 2 .times. 10-3 M histamine in the presence of 10-4 M impromidine). Histamine stimulation was competitively inhibited by the furane derivative ranitidine (Ki [inhibition constant] = 0.16 .times. 10-6 M) and by the imidazole analogs oxmetidine (Ki = 0.48 .times. 10-6 M) and cimetidine (Ki = 0.65 .times. 10-6 M); however, the H1 antagonist diphenhydramine inhibited histamine action at about 100-300 times higher concentrations (Ki = 51 .times. 10-6 M). Prostaglandin E1 (PGE1) also stimulated cAMP levels (50-fold increase) in HL-60 cells; half-maximal activation by PGE1 occurred at 3.2 .times. 10-6 M. Prostaglandin and histamine H2 receptors are evidently present and functional at an early stage during myeloid differentiation, and there is no substantial difference between the pharmacological properties of the histamine H2 receptors in HL-60 cells and in mature human peripheral neutrophils. The remarkable capacity for cAMP formation noted in HL-60 leukemic cells after cell surface interaction by histamine or prostaglandin suggests that cAMP and agents which increase its formation may have a role in the regulation of proliferation and/or differentiation of human myeloid progenitor cells.This publication has 18 references indexed in Scilit:
- Cimetidine and Granulopoiesis: Bone Marrow Culture Studies in Normal Man and Patients with Cimetidine-associated NeutropeniaBritish Journal of Haematology, 1980
- Studies on the activities, kinetic properties and subcellular localisation of cyclic amp phosphodiesterase in human neutrophil leukocytesClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- Gastric secretory studies in humans with impromidine (SK&F 92676)—a specific histamine H2 receptor agonistGastroenterology, 1980
- PHARMACODYNAMIC BASIS FOR THE INTERACTION OF CIMETIDINE WITH THE BONE-MARROW STEM-CELLS (CFU-S)1980
- Functional changes in human leukemic cell line HL-60. A model for myeloid differentiationThe Journal of cell biology, 1979
- Cimetidine-induced neutropenia: a possible dose-related phenomenonArchives of internal medicine (1960), 1979
- Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide.The Journal of Experimental Medicine, 1979
- Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.Proceedings of the National Academy of Sciences, 1978
- Mechanism for histamine H2-receptor induced cell-cycle changes in the bone marrow stem cellInflammation Research, 1977
- ROLE OF CYCLIC NUCLEOTIDES IN PROLIFERATION OF COMMITTED GRANULOCYTE-MACROPHAGE PROGENITOR CELLS1977